Sustainable Development Report 2019 of Imexpharm Corporation

By Quốc Huy
24/06/2020 - 10:01

Being a responsible pharmaceutical company with outstanding quality and standard in Vietnam, we bear in mind the duties of protect and take care for public health. In addition to offer suffcient medicines to meet market demand during the pandemic, Imexpharm has contributed 500 million dong to advocate Dong Thap province in order to tackle the epidemic. Moreover, we are active to protect labor health by implementing many methods such as work from home in order for Imexpharm staff to be safe and overcome the pandemic.

Related post

New product

ATORVIS 20 thuốc hạ lipid

ATORVIS 20 thuốc hạ lipid Atorvastatin là thuốc hạ lipid máu thuộc nhóm statin - là...

Claminat® 625mg

Please contact us for more information! Amoxicillin là kháng sinh bán tổng hợp thuộc nhóm β...

PMS-MEXCOLD 650

Đang cập nhật

INTRODUCTION VIDEO